TASLY(SH:600535) Zheng Quan Zhi Xing·2025-09-02 16:15Core Viewpoint - Tianjin Tasly Pharmaceutical Group Co., Ltd. held its 13th meeting of the 9th Board of Directors on September 2, 2025, where significant resolutions were passed regarding the company's operational strategies and governance [1]. Group 1 - The meeting was attended by 14 out of 15 board members, with one member delegating their voting rights [1]. - The meeting was conducted in compliance with the Company Law and the company's articles of association, ensuring its legality and effectiveness [1]. - The resolutions passed during the meeting included a detailed action plan titled "Quality Improvement and Efficiency Enhancement to Return on Investment," which is available on the Shanghai Stock Exchange website [1]. Group 2 - The voting results showed unanimous support, with 15 votes in favor, 0 against, and 0 abstentions [2].